(DB-1251)
Our RT-PCR Panel for Diagnostics of Respiratory Viruses offers a parallel detection of: SARS-CoV-2, Influenza A, Influenza B and RSV. This comprehensive approach ensures that healthcare professionals can quickly and accurately diagnose patients, leading to timely and effective treatment.
With ultra-sensitive analysis, it picks up even the faintest traces of pathogens (LOD 2 to 10 copies), ensuring that no infection goes undetected. This level of sensitivity is crucial for early intervention and controlling the spread of diseases. With the DBdirect™ Technology featuring no need for RNA isolation it is a time-saving and more reliable solution.
Package size
Key Parameters: Direct parallel detection of respiratory viruses
Significantly faster and simpler laboratory process suitable for nasopharyngeal swabs and saliva
It works with standard collection media on swabs (except for inactivation media)
Manual and automated sample processing
Ordering info
Cat. no. | Quantity | Lead Time |
|---|---|---|
DBdirect™ Respiratory Panel 1 (DB-1251) | 100rxns | In Stock |
DBdirect™ Respiratory Panel 1 (DB-1251) | 1000rxns | In Stock |
Downloads
Document name | Download |
|---|---|
subtitle
Related Products
DBdirect™ COVID-19 Multiplex RT-PCR Kit
The highly robust, patent-protected RT-PCR mix formulation allows direct detection without prior RNA isolation, significantly speeding up and simplifying the lab process for nasopharyngeal swabs and saliva.
DBdirect™ COVID-19 Multiplex RT-PCR Kit 2
The highly robust, patent-protected RT-PCR mix formulation allows direct detection without prior RNA isolation, significantly speeding up and simplifying the lab process for nasopharyngeal swabs and saliva.
RT-PCR Respiratory Panel 2
RT-PCR Respiratory Panel 2ensures high sensitivity with an LOD 95% at two copies of SARS-CoV-2, enabling fast sample analysis in 80 minutes and compatibility with CE-IVD automated systems.
